Skip to main content
Premium Trial:

Request an Annual Quote

Ralph Snyderman, Francis Collins, David Sidransky, Michael Liebman

Premium
Ralph Snyderman has been awarded the 2007 Leadership in Personalized Medicine Award from the Personalized Medicine Coalition. Snyderman is chancellor emeritus at Duke University and founder and chairman of Proventys. Snyderman has been a Howard Hughes Medical Institute investigator, a Duke University researcher, and he was senior VP at Genentech.
 

 
The Will Rogers Institute will give its annual prize for Outstanding Contributions to Lung Research to Francis Collins, director of the National Human Genome Research Institute, on Dec. 6. The institute said it selected Collins for his research that led to the identification of the CFTR gene that is linked to lung diseases in some of its mutations.
 

 
Gene Express has appointed David Sidransky and Michael Liebman to its scientific advisory board. Sidransky is director of the Head and Neck Cancer Research Division at Johns Hopkins University’s School of Medicine. He also has been a director at ImClone and he has served on scientific advisory boards at MedImmune, Amgen, and Veridex, and he is vice chairman at Alfacell.
 
Liebman is managing director of Strategic Medicine and is a senior institute fellow at the Windber Research Institute. He was director of computational biology and biomedical informatics at the Abramson Family Cancer Research Institute at the University of Pennsylvania. Liebman also was global head of computational genomics at Roche Pharmaceuticals, director of bioinformatics and pharmacogenomics at Wyeth Pharmaceuticals, and he was director of genomics for Vysis.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.